Initial STP705 Phase I Trial Results Show Fat Reduction
Sirnaomics' STP705 is a drug candidate for fat reduction in adults undergoing abdominoplasty. The STP705 Phase I trial results show signs of efficacy and safety.
Sirnaomics' STP705 is a drug candidate for fat reduction in adults undergoing abdominoplasty. The STP705 Phase I trial results show signs of efficacy and safety.
The American Academy of Facial Plastic and Reconstructive Surgery has released its top five aesthetic trends for 2026, with a focus on regeneration, precision, and personalization.